The Nature and Treatment of Anxiety Disorders |
From inside the book
Results 1-3 of 28
Page 171
... Phase II Stop medication Sessions 17-22 ( Weeks 26-31 ) Reduce and stop medication . Prepare for relapse . Phase III Maintenance Sessions 31-36 ( Weeks 31-41 ) Relapse coping . Long - term maintenance . patient's symptomatology ...
... Phase II Stop medication Sessions 17-22 ( Weeks 26-31 ) Reduce and stop medication . Prepare for relapse . Phase III Maintenance Sessions 31-36 ( Weeks 31-41 ) Relapse coping . Long - term maintenance . patient's symptomatology ...
Page 343
... phase and a transition phase . The intensive phase consists of six 3 - hour sessions over a 2 - week period . It gives the patient 18 hours of inten- sive integrated education , cognitive therapy , and therapist - assisted exposure ...
... phase and a transition phase . The intensive phase consists of six 3 - hour sessions over a 2 - week period . It gives the patient 18 hours of inten- sive integrated education , cognitive therapy , and therapist - assisted exposure ...
Page 367
... PHASE This phase of the program is designed to help the patient make the transition from the intensive therapist - directed exposure therapy to independent self - directed exposure practice in the " real world . " The patients will be ...
... PHASE This phase of the program is designed to help the patient make the transition from the intensive therapist - directed exposure therapy to independent self - directed exposure practice in the " real world . " The patients will be ...
Contents
Theories of Anxiety | 15 |
Anxiety Syndromes and Disorders | 43 |
An Overview of Symptom | 69 |
Copyright | |
13 other sections not shown
Other editions - View all
Common terms and phrases
activity acute agoraphobia agoraphobic agoraphobic patients alcohol alprazolam antidepressants anxiety disorders anxiolytic anxious patients arousal assessment associated avoidance behavior therapy Behaviour Research benzodiazepines buspirone BZDs cause changes chapter clinical cognitive therapy common coping criteria depression developed diagnosis diazepam discussed dose drive drugs DSM-III-R evaluation experience experienced exposure therapy factors feeling frequently function heart rate hyperventilation iety imipramine important increased intensity intervention involved Journal of Psychiatry Joyce lactate locus coeruleus lorazepam MAOI measures medication ment months muscle occur onset panic attacks panic disorder panic disorder patients patients with panic percent person phenelzine physiologic practice present problems procedure propanolol Psychiatry psychological psychotherapy reduce relaxation reported Research and Therapy response self-efficacy self-statements sensations session side effects simple phobias social phobia social phobics somatic stimuli stress studies syndrome tasks TCAs theory therapeutic therapist thoughts tients tion treat treatment vivo exposure walk weeks withdrawal worry